JYONG BIOTECH LTD (MENS) Stock News

USA - NASDAQ:MENS - KYG831161065 - Common Stock

29.35 USD

-0.5 (-1.68%)

Last: 11/19/2025, 2:57:04 PM

Technical Analysis

Fundamental Analysis

Analyst Ratings

Earnings Estimates

MENS Latest News, Press Relases and Analysis

All

Press Releases

3 days ago - By: Benzinga - Mentions: PACS SLRX ANVS IMCC ...

12 Health Care Stocks Moving In Monday's Intraday Session

19 days ago - By: Benzinga - Mentions: MNOV INTS KALA EDSA ...

12 Health Care Stocks Moving In Friday's After-Market Session

2 months ago - By: Jyong Biotech Ltd.

Jyong Biotech Wins Innovation Gold Award in Pharmaceutical Category at 2025 Taipei Biotech Awards

2 months ago - By: Jyong Biotech Ltd.

Jyong Biotech Chairwoman and CEO Set to Attend as Speaker at 2025 Global Business Forum in Taipei

2 months ago - By: Jyong Biotech Ltd.

Jyong Biotech Announces Completion of Patient Enrollment of over 700 subjects in Phase II Clinical Trial of MCS‑8 for Prostate Cancer Prevention

3 months ago - By: The Motley Fool - Mentions: CGTX IPDN HILS EQ

These Were the 5 Top-Performing Stocks in the Nasdaq Composite in August 2025

3 months ago - By: Jyong Biotech Ltd.

Jyong Biotech Ltd. Participated in the 22nd Urological Association of Asia Congress to Display the Clinical Data for its Phase III Studies of BOTRESO and Phase II Study of MCS-8 (PCP)

4 months ago - By: Jyong Biotech Ltd.

Jyong Biotech Ltd. Rings Nasdaq Bell and Participates at the BIO 2025 International Convention

5 months ago - By: Jyong Biotech Ltd.

Jyong Biotech Ltd. Announces Closing of $20 Million Initial Public Offering

5 months ago - By: Jyong Biotech Ltd.

Jyong Biotech Ltd. Announces Pricing of $20 Million Initial Public Offering